FDA Approves Spineart’s Cervical Cage System

Implant combines function of interbody device and cervical plate.

Spineart has earned U.S. Food and Drug Administration (FDA) approval for its Scarlet AC-T cervical cage system. It is touted as a device that combines the functionality of an interbody device and cervical plate in one implant.

The locking mechanism of the screw head is completely integrated within the cage, reducing the profile and potential risks associated with dysphagia. The Titanium sandblasted surfaces of the implant facilitate primary stability and osseointegration, according to the company.

The screws are designed to allow stabilization while securing the cage.

Spineart SA is based in Switzerland with U.S. headquarters in New York City, N.Y. The company makes spine surgical devices and instruments.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters